Literature DB >> 3174366

Quality control of hospital formularies.

T D Rucker1.   

Abstract

This paper identifies various uses of the formulary concept, outlines factors that underlie the need for such an administrative device, and reviews four barriers to effective formulary control. It then examines selected components of the formulary system and specifies the need for supporting techniques, both internal and external. Twelve guidelines for developing a model drug formulary are presented. While administrative elements associated with implementation of a formulary are stressed, concerns about more intangible behavioural forces are introduced.

Mesh:

Year:  1988        PMID: 3174366     DOI: 10.1007/bf01959422

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  31 in total

1.  The foremost dilemma in managing a hospital formulary.

Authors:  R P Hoffmann
Journal:  Hosp Pharm       Date:  1982-05

2.  Effective formulary development--which direction?

Authors:  T D Rucker
Journal:  Top Hosp Pharm Manage       Date:  1981-05

3.  Drug information: findings from a major study of formularies.

Authors:  T D Rucker
Journal:  Drug Inf J       Date:  1979 Jan-Jun

4.  ASHP statement on the formulary system.

Authors: 
Journal:  Am J Hosp Pharm       Date:  1986-11

5.  Point: the formulary system and the emperor's new clothes.

Authors:  J A Green
Journal:  Am J Hosp Pharm       Date:  1986-11

6.  Computer-based system for maintaining and printing a hospital formulary.

Authors:  L A Sateren; T W Sudds; L S Tyler
Journal:  Am J Hosp Pharm       Date:  1987-06

7.  Improving patient care and pharmacy management: the effect of hospital formularies.

Authors:  R J Plumridge; J U Stoelwinder; C G Berbatis
Journal:  Drug Intell Clin Pharm       Date:  1984 Jul-Aug

8.  Hospitals defend formulary decisions against industry attacks.

Authors:  C R Talley
Journal:  Am J Hosp Pharm       Date:  1978-09

9.  Evaluation of pharmacy and therapeutics committee drug evaluation reports.

Authors:  P L Majercik; J R May; R L Longe; M H Johnson
Journal:  Am J Hosp Pharm       Date:  1985-05

10.  Reducing the pill swill: an audit of clinical pharmacy.

Authors:  P M Brooks; J Jones; R Lawrence; R Ali
Journal:  Med J Aust       Date:  1977-09-24       Impact factor: 7.738

View more
  7 in total

1.  Drug and Therapeutics (D & T) committees in Dutch hospitals: a nation-wide survey of structure, activities, and drug selection procedures.

Authors:  R Fijn; J R Brouwers; R J Knaap; L T De Jong-Van Den Berg
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

2.  Dutch hospital drug formularies: pharmacotherapeutic variation and conservatism, but concurrence with national pharmacotherapeutic guidelines.

Authors:  R Fijn; S A Engels; J R Brouwers; R J Knaap; L T De Jong-Van den Berg
Journal:  Br J Clin Pharmacol       Date:  2000-03       Impact factor: 4.335

3.  The quality of Dutch hospital drug formularies: evaluation of technical features and organisational information.

Authors:  R Fijn; C S de Vries; S A Engels; J R Brouwers; C J de Blaey; L T de Jong-van den Berg
Journal:  Pharm World Sci       Date:  1999-06

4.  Determinants of hospital drug expenditures in Western Europe.

Authors:  P Thürmann; S Harder
Journal:  Pharmacoeconomics       Date:  1993-09       Impact factor: 4.981

Review 5.  Pharmacoeconomic consequences of measurement and modification of hospital drug use.

Authors:  L L Ioannides-Demos; G M Eckert; A J McLean
Journal:  Pharmacoeconomics       Date:  1992-07       Impact factor: 4.981

6.  A review of limited lists and formularies: are they cost-effective?

Authors:  M J Pearce; E J Begg
Journal:  Pharmacoeconomics       Date:  1992-03       Impact factor: 4.981

7.  [Structure and activities of drug committees in Germany. Results of a survey of 143 hospitals. Pharmaco-economic Study Group and Rational Drug Therapy of the German Society of Clinical Pharmacology and Therapy].

Authors:  S Harder; P Thürmann; A Steioff
Journal:  Med Klin (Munich)       Date:  1998-02-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.